On The Web![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif){kind=icon}
Site SearchMorrisville, N.C. — Biopharmaceutical development firm Trimeris faces a lawsuit over the HIV drug it developed called Fuzeon.
In a Securities and Exchange Commission filing on Tuesday, Trimeris (Nasdaq: TRMS) said it had been sued by Novartis. Roche, Trimeris’ partner in developing and selling Fuzeon, is also included in the suit.
Novartis is alleging patent infringement. According to Trimeris, Novartis received the patent at the center of the case, about one month ago.
Fuzeon was approved for sale in 2003.
Trimeris Faces Lawsuit over HIV Drug
Copyright 2009 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Updated at 7:42 a.m. - As Nortel’s final demise nears, what blame should its board shoulder?
Posted at 7:03 a.m. - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Posted at 6:43 a.m. - 20/20: Surgery can let you see like a child again
Posted at 6:29 a.m. |
- CDC: US swine flu cases rise to nearly 34,000
Updated at 6:30 a.m.
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement